Samumed
Toggle navigation
Home
About
Company
Technology
Team
Contact Us
Advisors
Patients
Pipeline
Osteoarthritis
Degenerative Disc Disease
Idiopathic Pulmonary Fibrosis
Psoriasis
Tendinopathy
Androgenetic Alopecia
Oncology
Alzheimer’s Disease
Full Pipeline
Publications
News
Careers
SAMUMED NEWS
VIEW ALL
Samumed Closes on $438 Million in Equity Financing
Learn More
Samumed Presents Positive Preclinical Data on SM07883 at 2018 Alzheimer’s Association International Conference® (AAIC®)
Learn More
Samumed to Present Preclinical Data on SM07883, a Potential First-in-Class Alzheimer’s Disease Candidate, at the Alzheimer’s Association International Conference® (AAIC®) 2018
Learn More
ABOUT SAMUMED
Pipeline
Publications
Company
Team
Technology
×
The Wnt Pathway
Your browser does not support HTML5 video.